Newsbenzinga
Jaguar Health Portfolio Company Napo Pharmaceuticals Provides Its Novel Crofelemer Powder To Treat Intestinal Failure From Microvillus Inclusion Disease In The EU For Compassionate Use
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…